SERUM BILE ACID KINETICS & REGULATION OF BIOSYNTHESIS
SERUM BILE ACID KINETICS & REGULATION OF BIOSYNTHESIS
批准号:
3078998
负责人:
Gregory Thomas Everson
金额:
$7.44万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1986-03-31
中文摘要
这项提案的目的是调查负责
血清和胆汁酸池大小测量的差异
胆汁,以验证使用两个稳定同位素的单一样本血清技术
为了测量胆汁酸的动力学,研究
妊娠和口服避孕药对胆汁酸转化的影响
中间体7α-羟基-4-胆固酮-3-酮,为鹅去氧胆酸
并直接测定胆汁酸的合成
使用18O吸入技术。以下所有实验都将
使用气相色谱/质谱学/稳定同位素进行
比例法。胆汁和血清胆汁酸动力学将在5个月内进行比较
有胆囊症的受试者和5名受试者术后使用
13C-24-CDCA和13C-24-CA。在10名受试者中,我们将比较血清胆汁酸
用双倍同位素稀释法测定同一血清样品的动力学
与使用多样本血清技术的技术相同。在5年内
孕妇和5名服用避孕药的妇女我们将研究
关键胆汁酸中间体的转化,
7α-羟基-4-胆甾烯-3-酮(HCO)与CDCA和CA的反应
和13C-24-CDCA和13-24-CA。HCO组分代谢为CDCA和CDCA
将CA与CDCA和CA的产率进行比较。我们会
5例健康受试者断断续续直接测定胆汁酸合成
通过测定胆汁酸中180的掺入量来测定胆碱胺
吸入180度浓缩气后的羟基。这些
研究将解释我们观察到的池大小之间的差异
从血清和胆汁来衡量。它们将极大地扩展我们的能力
由于受试者依从性的提高和降低而导致的BLE酸动力学
质谱仪实验室中的分析时间。HCO研究可能
准确定位女性改变胆汁酸生物合成的途径
类固醇激素,从而提供关于
女性类固醇激素作用的细胞内定位。这
信息将有助于了解增生性心脏病的发病机制
女性患胆固醇结石的风险,尤其是暴露在高胆固醇环境下的女性
女性类固醇激素浓度。180项研究将验证一项
用于随后测量女性短期影响的技术
类固醇激素对胆汁酸合成的影响。
英文摘要
The aims of this proposal are to investigate the mechanism responsible for
observed differences in bile acid pool size measurements between serum and
bile, to validate a single sample serum technique using two stable isotopes
for measurement of bile acid kinetics, to investigate the effects of
pregnancy and oral contraceptive steroids on conversion of the bile acid
intermediate, 7 Alpha-hydroxy-4-cholesten-3-one, to chenodeoxycholic acid
(CDCA) and cholic acid (CA) and to directly measure bile acid synthesis
using an 18O inhalation technique. All of the following experiments will
be performed using gas chromatography/mass spectromatry/stable isotope
ratiometry. Biliary and serum bile acid kinetics will be compared in 5
subjects with gallbladders and 5 subjects post-cholecystectomy using
13C-24-CDCA and 13C-24-CA. In 10 subjects we will compare serum bile acid
kinetics obtained from one serum sample by double isotope dilution
technique with those using the multiple sample serum technique. In 5
pregnant women and 5 women taking contraceptive steroids we will study the
conversion of a key bile acid intermediate,
7Alpha-hydroxy-4-cholesten-3-one (HCO) to CDCA and CA, using deuterated HCO
and 13C-24-CDCA, and 13-24-CA. The fraction of HCO metabolized to CDCA AND
CA will be compared to the production rates of CDCA and CA. We will
directly measure bile acid synthesis in 5 healthy subjects on and off
cholestyramine by measuring the incorporation of 180 into bile acid
hydroxyl groups after inhalation of an 180 enriched atmosphere. These
studies will explain the difference we have observed between pool size
measured from serum and bile. They will greatly expand our ability to do
ble acid kinetics because of improved subject compliance and decreased
analytical time in the mass spectrometry laboratory. The HCO study may
pinpoint the pathway of bile acid biosynthesis that is altered by female
steroid hormones and thereby provide indirect information about the
intracellular localization of action of female steroid hormones. This
information will aid in understanding the pathogenesis of the increased
risk of cholesterol gallstones in women especially those exposed to high
concentrations of female steroid hormones. The 180 study will validate a
technique for subsequent measurement of the short-term effect of female
steroid hormones on bile acid synthesis.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
1987-03
期刊:
Journal of lipid research
影响因子:
6.5
作者:
[G. Everson]
通讯作者:
G. Everson
Hepatocyte-hepatoma cell hybrids. Characterization and demonstration of bile acid synthesis.
肝细胞-肝癌细胞杂交体。
DOI:
--
发表时间:
1986
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Polokoff,MA, Everson,GT]
通讯作者:
Everson,GT
HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation.
HepG2。
DOI:
--
发表时间:
1986
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Everson,GT, Polokoff,MA]
通讯作者:
Polokoff,MA
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8015117
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2010
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7719478
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7719422
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7719421
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL
-
批准号:7719472
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7604372
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
RESTORATION OF HEPATIC FUNCTION IN LIVING LIVER DONORS (ANCILLARY STUDY OF A2ALL
-
批准号:7604422
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7604428
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7604371
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2007
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7377765
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
A2ALL LADR PROTOCOL:PRE-TRNSPLNT TRTMNT TO PRVNT RCURRNCE OF HEPC AFT LVR TRNSPL
-
批准号:7377842
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7377766
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2006
-
负责人:Gregory Thomas Everson
-
依托单位:
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C)
-
批准号:7200525
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2005
-
负责人:Gregory Thomas Everson
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HCV (QLFT)
-
批准号:7200526
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2005
-
负责人:Gregory Thomas Everson
-
依托单位:
Quantitative Assessment of Hepatic Function
-
批准号:6982140
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2004
-
负责人:Gregory Thomas Everson
-
依托单位:
Hepatitis C Antiviral Treatment to Prevent Cirrhosis
-
批准号:6982139
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2004
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:7791894
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8131408
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:8145314
-
项目类别:
-
资助金额:$17.23万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
-
批准号:7938059
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2002
-
负责人:Gregory Thomas Everson
-
依托单位:
海外基金